Advances in Metered Dose Inhaler Technology: Formulation Development
Journal Title: AAPS PharmSciTech - Year 2014, Vol 15, Issue 2
Abstract
Pressurized metered dose inhalers (MDIs) are a long-standing method to treat diseases of the lung, such as asthma and chronic obstructive pulmonary disease. MDIs rely on the driving force of the propellant, which comprises the bulk of the MDI formulation, to atomize droplets containing drug and excipients, which ideally should deposit in the lungs. During the phase out of chlorofluorocarbon propellants and the introduction of more environmentally friendly hydrofluoroalkane propellants, many improvements were made to the methods of formulating for MDI drug delivery along with a greater understanding of formulation variables on product performance. This review presents a survey of challenges associated with formulating MDIs as solution or suspension products with one or more drugs, while considering the physicochemical properties of various excipients and how the addition of these excipients may impact overall product performance of the MDI. Propellants, volatile and nonvolatile cosolvents, surfactants, polymers, suspension stabilizers, and bulking agents are among the variety of excipients discussed in this review article. Furthermore, other formulation approaches, such as engineered excipient and drug-excipient particles, to deliver multiple drugs from a single MDI are also evaluated.
Authors and Affiliations
Paul B. Myrdal, Poonam Sheth, Stephen W. Stein
Keywords
Related Articles
- EP ID EP682388
- DOI 10.1208/s12249-013-0063-x
- Views 87
- Downloads 0
Process and Method Variability Modeling to Achieve QbD Targets
The online version of this article (doi:10.1208/s12249-015-0380-3) contains supplementary material, which is available to authorized users.
Hot Melt Extrusion: Development of an Amorphous Solid Dispersion for an Insoluble Drug from Mini-scale to Clinical Scale
The objective of the study was to develop an amorphous solid dispersion (ASD) for an insoluble compound X by hot melt extrusion (HME) process. The focus was to identify material-sparing approaches to develop bioavailable...
Application of Carrier and Plasticizer to Improve the Dissolution and Bioavailability of Poorly Water-Soluble Baicalein by Hot Melt Extrusion
Baicalein (purity > 95%) was supplied by China Pharmaceutical University, Nanjing, China. Kollidon VA64, Soluplus, Cremophor RH, and Poloxamer 188 were friendly supplied by Basf Auxiliary Chemical...
Multifunctional Nanoparticles for Prostate Cancer Therapy
The relapse of cancer after first line therapy with anticancer agents is a common occurrence. This recurrence is believed to be due to the presence of a subpopulation of cells called cancer stem cells in the tumor. There...
Development of an Ointment Formulation Using Hot-Melt Extrusion Technology
Ointments are generally prepared either by fusion or by levigation methods. The current study proposes the use of hot-melt extrusion (HME) processing for the preparation of a polyethylene glycol base ointment. Lidocaine...